Published in Ter Arkh on January 01, 2003
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology (2000) 3.49
Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology (1987) 3.24
Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol (1988) 3.21
Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet (1984) 2.83
NSAIDs, Cox-2 inhibitors, and the gut. Lancet (1995) 2.72
A simple method for assessing intestinal inflammation in Crohn's disease. Gut (2000) 2.69
A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet (1983) 2.62
A high-density integrated genetic linkage and radiation hybrid map of the laboratory rat. Genome Res (1999) 2.49
The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet (1984) 2.30
Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology (1983) 2.23
Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut (1996) 2.23
Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut (1986) 2.10
Food intolerance and Crohn's disease. Gut (1993) 1.84
Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability. Clin Sci (Lond) (1986) 1.78
High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut (1999) 1.63
The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease. Gastroenterology (1991) 1.61
The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis. Scand J Gastroenterol (1995) 1.57
Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol (2001) 1.54
Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut (1995) 1.54
Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine. Gut (1997) 1.53
Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut (1992) 1.42
Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut (1999) 1.42
Small intestine permeability in schizophrenia. Br J Psychiatry (1989) 1.41
Increased expression of c-myc proto-oncogene in biopsies of ulcerative colitis and Crohn's colitis. Gut (1992) 1.38
Quality control of home monitoring of blood glucose concentrations. Br Med J (Clin Res Ed) (1984) 1.38
Ten years' experience with an elemental diet in the management of Crohn's disease. Gut (1990) 1.37
Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther (2000) 1.36
Intestinal permeability to 51Cr-EDTA in rats with experimentally induced enteropathy. Gut (1985) 1.31
Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Clin Sci (Lond) (1985) 1.23
Upper gastrointestinal endoscopy performed by nurses: scope for the future? Gut (2003) 1.23
Intestinal permeability in patients with coeliac disease and dermatitis herpetiformis. Gut (1985) 1.22
In vitro determination of small intestinal permeability: demonstration of a persistent defect in patients with coeliac disease. Gut (1984) 1.20
Intestinal permeability: clinical correlates. Dig Dis (1986) 1.19
The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans. Gastroenterology (1998) 1.16
Expression of pp60c-src in human small cell and non-small cell lung carcinomas. Eur J Cancer (1992) 1.15
Studies on the enteropathy associated with primary hypogammaglobulinaemia. Gut (1994) 1.14
Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum (2001) 1.13
Intestinal permeability and inflammation in patients on NSAIDs. Gut (1998) 1.12
"Diaphragm-like" strictures of the small bowel in patients treated with non-steroidal anti-inflammatory drugs. Br J Radiol (1990) 1.10
Comparison of enteral feeding and total parenteral nutrition after liver transplantation. Lancet (1994) 1.08
Intestinal absorption and permeability in paediatric short-bowel syndrome: a pilot study. J Pediatr Gastroenterol Nutr (1999) 1.07
Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen. Gut (2001) 1.05
Diverticular disease hospital admissions are increasing, with poor outcomes in the elderly and emergency admissions. Aliment Pharmacol Ther (2009) 1.04
Mode of inheritance of hypertrophic cardiomyopathy in Iceland. Echocardiographic study. Br Heart J (1982) 1.04
Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma. Gut (2001) 1.04
The effect of intestinal hypoperfusion on intestinal absorption and permeability during cardiopulmonary bypass. Gastroenterology (1994) 1.04
Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine. Best Pract Res Clin Gastroenterol (2001) 1.03
Gastritis in patients on non-steroidal anti-inflammatory drugs. Histopathology (1993) 1.02
Effect of non-steroidal anti-inflammatory drugs on the human small intestine. Drugs (1986) 1.01
[Effect of selective proximal vagotomy on the protective barrier of the gastric mucosa]. Khirurgiia (Mosk) (1982) 1.01
Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? Postgrad Med J (2006) 1.01
Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation. Arthritis Rheum (1996) 1.00
Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugs. Arthritis Rheum (1994) 0.98
Coeliac syndrome: biochemical mechanisms and the missing peptidase hypothesis revisted. Gut (1984) 0.97
Sulphasalazine in ulcerative colitis: in memoriam? Gut (1991) 0.97
Nursing burns on special beds. Practical note. Scand J Plast Reconstr Surg Hand Surg (1987) 0.95
Non steroidal anti-inflammatory drugs, cyclooxygenase selectivity and gastrointestinal toxicity. Ital J Gastroenterol Hepatol (1998) 0.94
The prevention and healing of acute non-steroidal anti-inflammatory drug-associated gastroduodenal mucosal damage by misoprostol. Br J Rheumatol (1993) 0.93
Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study. Aliment Pharmacol Ther (2014) 0.93
Redistribution of proteins of fast axonal transport following administration of beta,beta'-iminodipropionitrile: a quantitative autoradiographic study. J Cell Biol (1982) 0.91
Enhancement of Fc receptor function during human monocyte differentiation in vitro. J Reticuloendothel Soc (1981) 0.91
A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity. Ann Rheum Dis (1996) 0.91
Intestinal permeability and absorptive capacity in children with portal hypertension. Scand J Gastroenterol (2002) 0.90
Comparison of leukocyte excretion and blood loss in inflammatory disease of the bowel. Gut (1993) 0.90
Giant lymph node hyperplasia (Castleman's disease) of the mesentery. Observations on the associated anemia. Gastroenterology (1984) 0.89
Tumor microembolism: pulmonary perfusion pattern. J Nucl Med (1984) 0.89
Rat gastrointestinal transglutaminase: demonstration of enzyme activity and cell and tissue distributions. Cell Biochem Funct (1985) 0.88
[Peripheral cancer of the lung and tuberculosis]. Arkh Patol (1986) 0.88
Mitogenic activities of amino acid substitution mutants of staphylococcal enterotoxin B in human and mouse lymphocyte cultures. Infect Immun (1996) 0.88
[The absorption of protein macromolecules in the gastrointestinal tract of adult mammals]. Usp Fiziol Nauk (1989) 0.88
Digestive-absorptive surface of the small bowel mucosa. Annu Rev Med (1968) 0.87
Cardiac arrhythmias in hypertrophic cardiomyopathy. Br Heart J (1982) 0.87
Alterations in nutritional status and disease activity during treatment of Crohn's disease with elemental diet. Scand J Gastroenterol (1995) 0.87
[Microalgae Spirulina in human nutrition]. Vopr Pitan (2004) 0.87
Intestinal permeability in patients with atopic eczema. Br J Dermatol (1985) 0.87
Assessment of ileal pouch inflammation by single-stool calprotectin assay. Dis Colon Rectum (2000) 0.87
Fecal calprotectin: a significant step in the noninvasive assessment of intestinal inflammation. J Pediatr Gastroenterol Nutr (2001) 0.86
Coronary steal through a patent internal mammary artery graft: treatment by subclavian angioplasty. Am Heart J (1993) 0.86
Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis. J Rheumatol (1997) 0.86
51Cr-EDTA test for intestinal permeability. Lancet (1984) 0.85
[Myocarditis and fibroplastic endocarditis in Wegener's granulomatosis]. Arkh Patol (2010) 0.85
Antibodies to colonic epithelial cells from the serum and colonic mucosal washings in ulcerative colitis. Gut (1995) 0.84
Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability. Ann Thorac Surg (1993) 0.84
The effects of a preassessment clinic on nonattendance rates for day-case colonoscopy. Endoscopy (2000) 0.84
Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat. Scand J Gastroenterol (2000) 0.84
Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease. Gut (1996) 0.83
Intestinal permeability defect in coeliac disease. Lancet (1983) 0.83
Significantly higher frequency of Helicobacter suis in patients with idiopathic parkinsonism than in control patients. Aliment Pharmacol Ther (2013) 0.83
Lateralization of LH-RH in rat hypothalamus. Brain Res (1984) 0.82
Effect of Pentavac and measles-mumps-rubella (MMR) vaccination on the intestine. Gut (2002) 0.82
[Morphologic and molecular-genetic characteristics of carcinoma, adenoma and surrounding tissue of the thyroid gland]. Arkh Patol (1998) 0.82
[Immunohistochemistry of biomolecular markers of early thyroid cancer]. Arkh Patol (1998) 0.82
Intestinal tolerability of nitroxybutyl-flurbiprofen in rats. Gut (1997) 0.82